Abeta-IN-9 (Compound 6i) is an amyloid beta-protein (Abeta) aggregation inhibitor. This compound effectively prevents the formation of nanorod structures by inhibiting Abeta aggregation, thereby blocking beta-sheet formation. Abeta-IN-9 is applicable in Alzheimers disease research.
Formel:
C17H17NO5
Target-Kategorie:
Beta Amyloid
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
